Thank you to our conference organizers, faculty, attendees and the Crohn’s & Colitis Foundation for their partnership on the 2020 Crohn’s & Colitis Congress®. Our third annual Congress had record attendance and offered unparalleled education. Here are some highlights from the meeting.
Select meeting headlines
- Colectomies for UC decline in the era of biologics
- Lymphoma risk low after TNF inhibitor treatments
- Diet-as-therapy in IBD relies on shared decision-making, compliance
Check out fun moments like this in our Facebook album